4//SEC Filing
Kirpekar Sahil 4
Accession 0001140361-24-013627
CIK 0001840904other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 8:16 PM ET
Size
8.8 KB
Accession
0001140361-24-013627
Insider Transaction Report
Form 4
Kirpekar Sahil
Chief Business Officer
Transactions
- Award
Stock Option
2024-03-13+550,000→ 550,000 totalExercise: $1.84Exp: 2034-03-13→ Common Shares (550,000 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-14−100,000→ 100,000 total→ Common Shares (100,000 underlying) - Exercise/Conversion
Common Shares
2024-03-14+100,000→ 100,000 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.
- [F2]The stock option shall vest as to 25% of the underlying shares on January 1, 2025, and in 36 substantially equal monthly installments thereafter.
Documents
Issuer
ATAI Life Sciences N.V.
CIK 0001840904
Entity typeother
Related Parties
1- filerCIK 0001951712
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 8:16 PM ET
- Size
- 8.8 KB